IL95321A - 4-Transformed History of G-) H] -014- Phnothiazine-01-Il (Alkyl [-2-Oxo-1-Oxa-8-Azaspiro] 4,5 [Decan, Preparation and Pharmaceutical Preparations Containing Them - Google Patents

4-Transformed History of G-) H] -014- Phnothiazine-01-Il (Alkyl [-2-Oxo-1-Oxa-8-Azaspiro] 4,5 [Decan, Preparation and Pharmaceutical Preparations Containing Them

Info

Publication number
IL95321A
IL95321A IL9532190A IL9532190A IL95321A IL 95321 A IL95321 A IL 95321A IL 9532190 A IL9532190 A IL 9532190A IL 9532190 A IL9532190 A IL 9532190A IL 95321 A IL95321 A IL 95321A
Authority
IL
Israel
Prior art keywords
formula
group
defined above
oxo
derivative
Prior art date
Application number
IL9532190A
Other languages
English (en)
Hebrew (he)
Other versions
IL95321A0 (en
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of IL95321A0 publication Critical patent/IL95321A0/xx
Publication of IL95321A publication Critical patent/IL95321A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL9532190A 1989-08-10 1990-08-09 4-Transformed History of G-) H] -014- Phnothiazine-01-Il (Alkyl [-2-Oxo-1-Oxa-8-Azaspiro] 4,5 [Decan, Preparation and Pharmaceutical Preparations Containing Them IL95321A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU894093A HU204529B (en) 1989-08-10 1989-08-10 Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
IL95321A0 IL95321A0 (en) 1991-06-30
IL95321A true IL95321A (en) 1994-02-27

Family

ID=10966862

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9532190A IL95321A (en) 1989-08-10 1990-08-09 4-Transformed History of G-) H] -014- Phnothiazine-01-Il (Alkyl [-2-Oxo-1-Oxa-8-Azaspiro] 4,5 [Decan, Preparation and Pharmaceutical Preparations Containing Them

Country Status (13)

Country Link
EP (1) EP0414422B1 (hu)
JP (1) JPH0377885A (hu)
KR (1) KR950001022B1 (hu)
AT (1) ATE103921T1 (hu)
AU (1) AU623545B2 (hu)
DD (1) DD299427A5 (hu)
DE (1) DE69007905T2 (hu)
DK (1) DK0414422T3 (hu)
ES (1) ES2052181T3 (hu)
HU (1) HU204529B (hu)
IL (1) IL95321A (hu)
NZ (1) NZ234845A (hu)
ZA (1) ZA906301B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU204054B (en) * 1989-08-10 1991-11-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives and pharmaceutical compositions comprising same
HU204530B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
KR940003491B1 (ko) * 1989-08-10 1994-04-23 리히터 게데온 베기에스제티 기아르 알.티 4,4-이중 치환된 피페리딘 유도체와 그 제조방법 및 상기 화합물을 함유하는 약제학적 조성물
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
FR2691459B1 (fr) * 1992-05-25 1995-06-09 Adir Nouveaux derives de la phenothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE329579T1 (de) 1999-11-12 2006-07-15 Abbott Lab Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
AU2004306004B9 (en) 2003-09-26 2011-08-18 Sony Interactive Entertainment Inc. Portable electronic device
CN100497346C (zh) * 2004-02-10 2009-06-10 弗·哈夫曼-拉罗切有限公司 趋化因子ccr5受体调控剂
KR20090127298A (ko) 2007-03-29 2009-12-10 에프. 호프만-라 로슈 아게 헤테로사이클릭 항바이러스 화합물
CA3094481A1 (en) 2018-04-06 2019-10-10 Camp4 Therapeutics Corporation Phenothiazine derivatives and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1256404A (en) * 1968-06-07 1971-12-08 Dainippon Pharmaceutical Co 0-oxa-3,8-diazaspiro(4,5)decan-2,4-diones
DE2118339A1 (de) * 1971-04-15 1972-10-26 Yoshitomi Pharmaceutical Industries Ltd, Osaka (Japan) Pipendinspiroverbindungen
US4255432A (en) * 1979-09-06 1981-03-10 Syntex (U.S.A.) Inc. 8-[2-3-Indolyl)ethyl]-1-oxa-3-,8-diazaspiro[4.5]decan-2-ones, pharmaceutical compositions thereof and methods of use thereof
FR2615515B1 (fr) * 1987-05-22 1989-06-30 Adir Nouveaux derives du spiro 4, 5 decane, leur procede de preparation et les compositions pharmaceutiques les renfermant
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost

Also Published As

Publication number Publication date
DD299427A5 (de) 1992-04-16
AU6080290A (en) 1991-02-14
JPH0377885A (ja) 1991-04-03
IL95321A0 (en) 1991-06-30
EP0414422A2 (en) 1991-02-27
HUT55784A (en) 1991-06-28
ES2052181T3 (es) 1994-07-01
ZA906301B (en) 1991-06-26
KR910004633A (ko) 1991-03-29
AU623545B2 (en) 1992-05-14
NZ234845A (en) 1992-03-26
HU204529B (en) 1992-01-28
EP0414422A3 (en) 1991-07-24
KR950001022B1 (ko) 1995-02-07
EP0414422B1 (en) 1994-04-06
DE69007905T2 (de) 1994-07-21
DE69007905D1 (de) 1994-05-11
ATE103921T1 (de) 1994-04-15
DK0414422T3 (da) 1994-05-16

Similar Documents

Publication Publication Date Title
EP0384349B1 (de) Substituierte Pyrrole
IE51015B1 (en) Heterocyclic compounds,processes for their preparation and pharmaceutical compositions containing them
IL95321A (en) 4-Transformed History of G-) H] -014- Phnothiazine-01-Il (Alkyl [-2-Oxo-1-Oxa-8-Azaspiro] 4,5 [Decan, Preparation and Pharmaceutical Preparations Containing Them
US5132309A (en) 2-oxo-3,8-diazaspiro(4,5)decane derivatives, pharmaceutical compositions containing them and process for preparing same
CA2354606C (en) Azabicycloalkane derivatives and therapeutic uses thereof
CA1248532A (en) Pyrazolo¬3,4-b|pyridine derivatives and process for producing them
AU650315B2 (en) Substituted 1,2,3,4-tetrahydrocyclopent(B)indoles, 1,2,3,3a,4,8a-hexahydrocyclopent(B)indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments
EP0412822B1 (en) 4,4-Disubstituted piperidine derivatives, processes for their preparation and pharmaceutical compositions thereof
Hino et al. Agents Acting on the Central Nervous System.: Synthesis of 3-Phenyl-2-piperazinyl-1-benzazocines, 3-Substituted-2-piperazinyl-1-benzazepines and Related Compounds
US5091541A (en) Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds
US4983616A (en) Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds
US5077295A (en) Antipsychoic 4-(4-(3-benzisothiazolyl)-1-piperazinyl)buytl bridged bicycle imides
US5118687A (en) 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives, pharmaceutical compositions containing them and process for preparing same
US3573323A (en) 1,2,3,4,5,10-hexahydroazepino(2,3-b)indoles
US3573324A (en) 2,3,4,5,10,10a-hexahydroazepino(2,3-b)indoles
CA2023014A1 (en) 2-oxo-1-oxa-8-azaspiro /4,5/decane derivatives, pharmaceutical compositions containing them and process for preparing the same
US3502683A (en) Certain n-substituted noratropine and nortropidine tropic acid esters and derivatives thereof
US4572911A (en) Hexahydroindolinzine compounds, pharmaceutical compositions and methods and intermediates
US4783455A (en) Substituted pyrimidoindoles and diazepinoindoles useful as hypoglycaemics
KR800000047B1 (ko) 치환된 6-아릴-4H-S-트리아졸로-[3,4c]-티에노-[2,3e]-1,4-디아제핀의 제조방법
US4975427A (en) 17-sulfur-20,21-dinor-eburnamenines
CA2023019A1 (en) 1-oxa-2-oxo-8-azaspiro/4,5/decane derivatives, pharmaceutical compositions containing them and process for preparing the same

Legal Events

Date Code Title Description
RH Patent void